Request Deal Involvement
Deep Track led a $158m Series B-2 round in TORL BioTherapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Schulte Roth & Zabel
legal advisors
Latham & Watkins
or
Principals
bidder
DEEP TRACK CAPITAL
bidder
VERTEX VENTURES
bidder
BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)
target
TORL BIOTHERAPEUTICS LLC
bidder
RA CAPITAL MANAGEMENT
bidder
PERCEPTIVE ADVISORS LLC
bidder
AVIDITY PARTNERS
bidder
GOLDMAN SACHS ALTERNATIVES
bidder
UC INVESTMENTS
bidder
BRISTOL MYERS SQUIBB COMPANY
bidder
MOORE STRATEGIC VENTURES
bidder
PERCEPTIVE XONTOGENY VENTURE FUND
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite